Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has an opportunity to report progress on its scope 1 and 2 emissions targets. These targets could be aligned with a 1.5-degree trajectory. Additionally, there is potential for the company to reduce its scope 1 and 2 greenhouse gas emissions. Furthermore, there is an opportunity for the company to decrease its scope 3 greenhouse gas emissions. To enhance transparency, it could disclose a time-bound target for reducing scope 3 emissions. Lastly, the company has a chance to report progress on these scope 3 targets, which could also align with a 1.5-degree trajectory.
Animal welfare
The company has an opportunity to disclose a commitment and targets that address key animal welfare issues in its supply chain.
Antibiotic use and growth promoting substances
The company has an opportunity to disclose a commitment and targets to reduce the use of antibiotics and growth promoting substances in its supply chain. Further, it could disclose a reduction in the total use of antibiotics classified as medically important antimicrobials by the World Health Organization.
Food loss and waste
The company has an opportunity to disclose its food loss and waste (FLW) reduction targets and report progress against these targets. Additionally, it can consider aligning its FLW reduction goal with SDG12.3, which aims for a 50% reduction by 2030.
Plastic use and packaging waste
The company has an opportunity to enhance its disclosures relating to plastic use reduction and its transition towards sustainable packaging.
Protein diversification
The company has an opportunity to set a sales-based target to increase alternative proteins across its portfolio, as well as report progress against this target.
Water withdrawal
The company has an opportunity to enhance its disclosures relating to water use and withdrawal.